TEMLIMM Trademark

Trademark Overview


On Wednesday, August 4, 2021, a trademark application was filed for TEMLIMM with the United States Patent and Trademark Office. The USPTO has given the TEMLIMM trademark a serial number of 90864755. The federal status of this trademark filing is REGISTERED as of Tuesday, May 30, 2023. This trademark is owned by AstraZeneca AB. The TEMLIMM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
temlimm

General Information


Serial Number90864755
Word MarkTEMLIMM
Filing DateWednesday, August 4, 2021
Status700 - REGISTERED
Status DateTuesday, May 30, 2023
Registration Number7064932
Registration DateTuesday, May 30, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 30, 2023REGISTERED-PRINCIPAL REGISTER
Friday, April 21, 20231(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, March 14, 2023NOTICE OF ALLOWANCE CANCELLED
Friday, April 21, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 14, 2023TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 27, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 2, 2022NON-FINAL ACTION E-MAILED
Wednesday, March 2, 2022NON-FINAL ACTION WRITTEN
Wednesday, March 2, 2022ASSIGNED TO EXAMINER
Wednesday, September 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 7, 2021NEW APPLICATION ENTERED